Xyngular Reviews

Public safety signals

7 adverse event reports in public records.

• Adverse eventJanuary 25, 2023Source: openFDA

  Adverse event report: Atrial fibrillation, Heart rate irregular

  Product: XYNGULAR ADVANCED OMEGA; XYNGULAR XYNG; XYNGULAR TRIMSTIX FRUIT PUNCH; XYNGULAR COMPLETE PROBIOTIC; XYNGULAR COMPLETE PREBIOTIC WITH ORGANIC FIBER; XYNGULAR COMPLETE COLLAGEN. Outcome: Hospitalization, Visited Emergency Room. Reactions: Atrial fibrillation, Heart rate irregular. FDA CAERS report 2023-CFS-000825.

• Adverse eventNovember 15, 2022Source: openFDA

  Adverse event report: Myocardial infarction

  Product: XYNGULAR AXION; XYNGULAR SPRYNG LEMON-LIME STICK PACK; XYNGULAR SHINE. Outcome: Life Threatening. Reactions: Myocardial infarction. FDA CAERS report 2022-CFS-016167.

• Adverse eventApril 30, 2021Source: openFDA

  Adverse event report: Dyspnoea, Hypersensitivity, Pallor

  Product: XYNGULAR 8 DAY ACCELERATE WITH THERMOLIT BLEND; XYNGULAR 8 DAY XYNG; XYNGULAR 8 DAY TRIMSTIX FRUIT PUNCH; XYNGULAR 8 DAY RESIST CHEW; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY FLUSH; XYNGULAR 8 DAY ACCELERATE WITH THERMOLIT BLEND. Outcome: Visited Emergency Room, Visited a Health Care Provider. Reactions: Dyspnoea, Hypersensitivity, Pallor. FDA CAERS report 2021-CFS-003916.

• Adverse eventApril 19, 2021Source: openFDA

  Adverse event report: Atrial fibrillation

  Product: XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR GLOBAL BLEND; XYNGULAR 8 DAY XYNG; XYNGULAR 8 DAY TRIMSTIX FRUIT PUNCH; XYNGULAR 8 DAY RESIST CHEW; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY LEAN CHOCOLATE; XYNGULAR 8 DAY FLUSH; XYNGULAR 8 DAY ACCELERATE WITH THERMOLIT BLEND; XYNGULAR 8 DAY ACCELERATE WITH THERMOLIT BLEND. Outcome: Other Serious or Important Medical Event, Visited a Health Care Provider, Other Serious Outcome. Reactions: Atrial fibrillation. FDA CAERS report 2021-CFS-003510.

• Adverse eventApril 19, 2021Source: openFDA

  Adverse event report: Gastrointestinal obstruction, Ileus

  Product: XYNGULAR AXION; XYNGULAR XYNG; XYNGULAR XYNG; XYNGULAR XR2; XYNGULAR LEAN VANILLA; XYNGULAR LEAN VANILLA; XYNGULAR GLOBAL BLEND CLASSIC; XYNGULAR GLOBAL BLEND CLASSIC; XYNGULAR FLUSH; XYNGULAR CHEAT; XYNGULAR CHEAT; XYNGULAR AXION; XYNGULAR ADVANCED OMEGA; XYNGULAR ACCELERATE WITH THERMOLIT; XYNGULAR ACCELERATE WITH THERMOLIT. Outcome: Other Serious or Important Medical Event, Other Serious Outcome. Reactions: Gastrointestinal obstruction, Ileus. FDA CAERS report 2021-CFS-003509.

• Adverse eventAugust 9, 2016Source: openFDA

  Adverse event report: Abdominal pain upper, Cystitis, Gastric disorder

  Product: XYNGULAR FOR WEIGHT LOSS. Outcome: Visited a Health Care Provider. Reactions: Abdominal pain upper, Cystitis, Gastric disorder. FDA CAERS report 199776.

• Adverse eventOctober 14, 2014Source: openFDA

  Adverse event report: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood bilirubin increased and 3 more

  Product: XYNGULAR. Outcome: Hospitalization. Reactions: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood bilirubin increased, Hepatitis cholestatic, Jaundice, Liver injury. FDA CAERS report 180022.

Products

1 product listed for Xyngular.

Lab tests